Back to all companies
Sign in
Back to all companies
Guardian Bio logo

Guardian Bio

Summer 2022Active

Dendritic cell-based platform for cancer therapy

Save
Guardian Bio logo

Guardian Bio

Summer 2022Active

Dendritic cell-based platform for cancer therapy

Save
Company details

Your immune system is your body’s best weapon and defense against cancer. It is only when it is overcome that cancer develops into full blown disease. Dendritic cells sit at the helm of the immune system, directing and dictating immune responses. Data has shown dendritic cells are often dysfunctional in cancer patients, and that this dysfunction is a bottleneck for other therapies.

Guardian Bio’s approach is focused on creating a dendritic cell-based product which drives anti-tumor activity through activating the killers of the immune system AND training them against multiple cancer targets. We take stem cells from cancer patients, turn them into specific therapeutic dendritic cells specially trained against that patient’s tumor, and re-introduce them back into the body.

Our therapeutic dendritic cells revitalize the killers of the immune system and give them the kickstart they need to fight - and win - against cancer.

Location
Boston, MA, USA
Founded
Unknown
Category
Biotech
YC Directory Pagewww.guardian-bio.com
Founders
  • AZ
    Ananya Zutshi
    Founder
    LinkedIn
  • RB
    Ricky Barrett
    Founder
    LinkedIn

Your immune system is your body’s best weapon and defense against cancer. It is only when it is overcome that cancer develops into full blown disease. Dendritic cells sit at the helm of the immune system, directing and dictating immune responses. Data has shown dendritic cells are often dysfunctional in cancer patients, and that this dysfunction is a bottleneck for other therapies.

Guardian Bio’s approach is focused on creating a dendritic cell-based product which drives anti-tumor activity through activating the killers of the immune system AND training them against multiple cancer targets. We take stem cells from cancer patients, turn them into specific therapeutic dendritic cells specially trained against that patient’s tumor, and re-introduce them back into the body.

Our therapeutic dendritic cells revitalize the killers of the immune system and give them the kickstart they need to fight - and win - against cancer.

Location
Boston, MA, USA
Founded
Unknown
Category
Biotech
YC Directory Pagewww.guardian-bio.com
Founders
  • AZ
    Ananya Zutshi
    Founder
    LinkedIn
  • RB
    Ricky Barrett
    Founder
    LinkedIn
Pro

Upgrade to Pro, then request the Guardian Bio teardown.

This company does not have a completed analysis yet. Choose a Pro plan first, then use one of your 5 monthly research requests to have our agent investigate Guardian Bio. The full teardown, rebuild plan, and technical specs unlock when it lands.

  • Use Pro to request the first Guardian Bio teardown and keep the finished report in your account.
  • Read every completed teardown and rebuild plan already in the database.
  • Unlock implementation-ready technical specs and 5 fresh research requests each month.

Choose your Pro plan

$20/ month

Find one worth rebuilding, get the teardown, open the implementation-ready specs, and use fresh report requests when you want deeper research.

See Pro plans
Full teardown library
Specs for every company
5 fresh requests / month
CLI for agent imports
Startups.RIP — Dead startups, alive ideas
PricingContactPrivacyGot feedback? DM @oscrhong